Vindesine sulfate

硫酸长春地辛

Report date: 2023/04/21 17:28:50
NME

Base Information

Drug NameVindesine sulfate
Drug Alias Name长春地辛硫酸盐长春地辛EldisineCompound-112531
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTubulin beta-1 chain inhibitors
TargetsTubulin beta-1 chain
Therapy Area/IndicationsSmall Cell Lung CarcinomaCarcinoma, Non-Small-Cell LungLung Neoplasms +[8] 
Global Approved IndicationsSmall Cell Lung CarcinomaCarcinoma, Non-Small-Cell LungLung Neoplasms +[8] 
Approved Indications in ChinaSmall Cell Lung CarcinomaCarcinoma, Non-Small-Cell LungEsophageal Neoplasms +[6] 
Original Approved Country/TerritoryUnited Kingdom
Original Approved Date1979/01/01
Country/TerritoryUnited KingdomMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesEli Lilly And CompanyGuangzhou Hanfang Pharmaceutical Company Ltd
Inactive CompaniesN/A
Active IndicationsSmall Cell Lung CarcinomaCarcinoma, Non-Small-Cell LungLung Neoplasms +[8] 
Inactive IndicationsN/A

Other Information

ATC CodeL01CA03
Related LinksWikipediaDrugBankKEGG